Literature DB >> 16930083

Chronic non-infectious uveitis in the elderly: epidemiology, pathophysiology and management.

Rajen Gupta1, Philip I Murray.   

Abstract

Intraocular inflammatory diseases are collectively known as uveitis. The aetiology of this condition can be diverse, as inflammation may result from direct involvement of the uveal tract or indirect inflammation of adjacent tissues. Uveitis can present challenges to diagnosis and treatment, and is potentially a severe sight-threatening disease. In the elderly, uveitis can present de novo after the age of 60 years or may represent a process earlier in life continuing after the age of 60 years, although many cases will have become quiescent by that time. More recent studies suggest that uveitis presenting after 60 years of age is more common than previously believed. Most cases of uveitis are of unknown aetiology and are classed as idiopathic, although sarcoidosis, ocular ischaemia and birdshot chorioretinopathy are recognised non-infectious causes of uveitis in the elderly. Systemic immunosuppression, with its well known complications, may be required to preserve vision. In this age group, one should always have high suspicion of a masquerade syndrome, particularly a primary CNS non-Hodgkin's lymphoma. With the demographics of the elderly population changing and mean life expectancy increasing, it is important that clinicians are familiar with uveitis as a potential cause of visual impairment in this age group.

Entities:  

Mesh:

Year:  2006        PMID: 16930083     DOI: 10.2165/00002512-200623070-00001

Source DB:  PubMed          Journal:  Drugs Aging        ISSN: 1170-229X            Impact factor:   3.923


  135 in total

1.  Prediction of benefit from carotid endarterectomy in individual patients: a risk-modelling study. European Carotid Surgery Trialists' Collaborative Group.

Authors:  P M Rothwell; C P Warlow
Journal:  Lancet       Date:  1999-06-19       Impact factor: 79.321

Review 2.  Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel.

Authors:  D A Jabs; J T Rosenbaum; C S Foster; G N Holland; G J Jaffe; J S Louie; R B Nussenblatt; E R Stiehm; H Tessler; R N Van Gelder; S M Whitcup; D Yocum
Journal:  Am J Ophthalmol       Date:  2000-10       Impact factor: 5.258

Review 3.  Criteria for diagnosis of Behçet's disease. International Study Group for Behçet's Disease.

Authors: 
Journal:  Lancet       Date:  1990-05-05       Impact factor: 79.321

4.  Fas ligand-induced apoptosis as a mechanism of immune privilege.

Authors:  T S Griffith; T Brunner; S M Fletcher; D R Green; T A Ferguson
Journal:  Science       Date:  1995-11-17       Impact factor: 47.728

Review 5.  Biology of multifunctional cytokines: IL 6 and related molecules (IL 1 and TNF).

Authors:  S Akira; T Hirano; T Taga; T Kishimoto
Journal:  FASEB J       Date:  1990-08       Impact factor: 5.191

6.  Increased frequencies of interleukin-2- and interferon-gamma-producing T cells in patients with active Behçet's disease.

Authors:  N Sugi-Ikai; M Nakazawa; S Nakamura; S Ohno; M Minami
Journal:  Invest Ophthalmol Vis Sci       Date:  1998-05       Impact factor: 4.799

Review 7.  Glaucoma associated with uveitis.

Authors:  R S Moorthy; A Mermoud; G Baerveldt; D S Minckler; P P Lee; N A Rao
Journal:  Surv Ophthalmol       Date:  1997 Mar-Apr       Impact factor: 6.048

Review 8.  Uveitis: what do we know and how does it help?

Authors:  S Lightman
Journal:  Clin Exp Ophthalmol       Date:  2001-04       Impact factor: 4.207

9.  Uveitis and diabetes mellitus.

Authors:  A Rothova; C Meenken; R P Michels; A Kijlstra
Journal:  Am J Ophthalmol       Date:  1988-07-15       Impact factor: 5.258

10.  Uveitis in older patients.

Authors:  T A Makley; R G Orlando
Journal:  Ann Ophthalmol       Date:  1982-10
View more
  15 in total

Review 1.  Understanding the role of aldose reductase in ocular inflammation.

Authors:  U C S Yadav; S K Srivastava; K V Ramana
Journal:  Curr Mol Med       Date:  2010-08       Impact factor: 2.222

Review 2.  Emerging role of antioxidants in the protection of uveitis complications.

Authors:  U C S Yadav; N M Kalariya; K V Ramana
Journal:  Curr Med Chem       Date:  2011       Impact factor: 4.530

3.  Nanomicellar Topical Aqueous Drop Formulation of Rapamycin for Back-of-the-Eye Delivery.

Authors:  Kishore Cholkar; Sriram Gunda; Ravinder Earla; Dhananjay Pal; Ashim K Mitra
Journal:  AAPS PharmSciTech       Date:  2014-11-26       Impact factor: 3.246

4.  Neoplastic masquerade syndromes in patients with uveitis.

Authors:  Landon K Grange; Amr Kouchouk; Monica D Dalal; Susan Vitale; Robert B Nussenblatt; Chi-Chao Chan; H Nida Sen
Journal:  Am J Ophthalmol       Date:  2013-11-06       Impact factor: 5.258

5.  Aldose reductase inhibition prevents endotoxin-induced uveitis in rats.

Authors:  Umesh C S Yadav; Satish K Srivastava; Kota V Ramana
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-10       Impact factor: 4.799

6.  Prevention of endotoxin-induced uveitis in rats by benfotiamine, a lipophilic analogue of vitamin B1.

Authors:  Umesh C S Yadav; Sumitra Subramanyam; Kota V Ramana
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-01-10       Impact factor: 4.799

Review 7.  Primary intraocular lymphoma: diagnosis and differential diagnosis.

Authors:  H Nida Sen; Bahram Bodaghi; Phuc Le Hoang; Robert Nussenblatt
Journal:  Ocul Immunol Inflamm       Date:  2009 May-Jun       Impact factor: 3.070

Review 8.  A Glimpse into Uveitis in the Aging Eye: Pathophysiology, Clinical Presentation and Treatment Considerations.

Authors:  Elizabeth Akinsoji; Raquel Goldhardt; Anat Galor
Journal:  Drugs Aging       Date:  2018-05       Impact factor: 4.271

Review 9.  Birdshot retinochoroidopathy.

Authors:  Albert T Vitale
Journal:  J Ophthalmic Vis Res       Date:  2014 Jul-Sep

10.  Ocular tolerability and efficacy of intravitreal and subconjunctival injections of sirolimus in patients with non-infectious uveitis: primary 6-month results of the SAVE Study.

Authors:  Quan Dong Nguyen; Mohamed A Ibrahim; Anthony Watters; Millena Bittencourt; Jithin Yohannan; Yasir J Sepah; James P Dunn; Joel Naor; Naveed Shams; Ovais Shaikh; Henry Alexander Leder; Diana V Do
Journal:  J Ophthalmic Inflamm Infect       Date:  2013-02-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.